The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rapid drop in blood platelet count and increase in creatinine in non-small cell lung cancer (NSCLC) patients treated with osimertinib.
 
Inger Johanne Zwicky Eide
No Relationships to Disclose
 
Aslaug Helland
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Simon Ekman
No Relationships to Disclose
 
Saulius Cicenas
No Relationships to Disclose
 
Jussi Koivunen
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Bjørn Henning Grønberg
Employment - Lilly (I)
Stock and Other Ownership Interests - Lilly (I)
Honoraria - AstraZeneca; Lilly; MSD
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD
 
Odd Terje Brustugun
Honoraria - AstraZeneca; Boehringer Ingelheim; MSD Oncology; Novartis
Consulting or Advisory Role - MSD Oncology (Inst)
Research Funding - Abbvie (Inst); ARIAD (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)